MolecuLight Secures $27.5 Million From Hayfin, a Leading Healthcare Institutional Investor

Strategic financing will enable MolecuLight to further accelerate commercialization PITTSBURGH, Jan. 6, 2025 /PRNewswire/ — MolecuLight Inc., a global medical device company pioneering point-of-care fluorescence imaging for measuring bacterial load in wounds, today announced it has…

Go to Source